HomeMy WebLinkAboutMINUTES - 03312015 - C.94RECOMMENDATION(S):
Approve and authorize the Purchasing Agent, on behalf of Health Services Department, to execute a blanket Purchase
Order #34719 with Qiagen, Inc. in the amount of $200,000 for Quantiferon collection blood tubes and test kits for the
period of March 1, 2015 to February 29, 2016
FISCAL IMPACT:
100% funding is included in the Enterprise Fund I Budget and includes a $65,000 contract with Chevron Corp. to
perform this testing for their employees.
BACKGROUND:
Qiagen Inc. has been used by the Health Services Department for over ten (10) years. Qiagen, Inc. provides the
reagents required for use with testing instruments in our Public Health Laboratory. The reagents are necessary for
specimens to be tested for tuberculosis, both active and latent infections. The Quantiferon test is a specific blood test
that detects TB antigen in the blood of patients who have been exposed to the tuberculosis organism. A positive test
would alert the provider to provide treatment and alleviate disease in later years.
APPROVE OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR RECOMMENDATION OF BOARD COMMITTEE
Action of Board On: 03/31/2015 APPROVED AS RECOMMENDED OTHER
Clerks Notes:
VOTE OF SUPERVISORS
AYE:Candace Andersen, District II
Supervisor
Mary N. Piepho, District III
Supervisor
Karen Mitchoff, District IV
Supervisor
ABSENT:John Gioia, District I
Supervisor
Federal D. Glover, District V
Supervisor
Contact: Anna Roth, 370-5101
I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the
Board of Supervisors on the date shown.
ATTESTED: March 31, 2015
David Twa, County Administrator and Clerk of the Board of Supervisors
By: Chris Heck, Deputy
cc: T Scott, C Rucker , M Harris
C. 94
To:Board of Supervisors
From:William Walker, M.D., Health Services Director
Date:March 31, 2015
Contra
Costa
County
Subject:Qiagen, Inc. Purchase Order
CONSEQUENCE OF NEGATIVE ACTION:
The consequences of negative actions would be that the health care system would not be able to detect TB antigen in
those patients who have been exposed, resulting in higher health care cost when they develop disease in later years.
The tests would then need to be conducted by outside labs at a greater cost to the county. Public Heath Lab also uses
the reagents purchased from Qiagen to conduct similar testing for the Chevron Corporation which generates revenue
for CCC. Without the reagents we would not be able to conduct the tests.
CHILDREN'S IMPACT STATEMENT:
Not applicable.